|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
4/30/2008 11:10:19 AM
PRINCETON, N.J., April 29, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company that develops and markets dermatology products, today announced its financial results for the first quarter ended March 31, 2008. Total revenues were $8.4 million for the first quarter of 2008, up $5.6 million or 207% from $2.7 million in the first quarter of 2007. Net loss for the first quarter of 2008 was $14.0 million, or $0.40 per share, and represents a decrease of $1.4 million or 9% from the net loss of $15.4 million, or $0.53 per share in the same period last year. First quarter 2008 net loss includes $2.6 million of one time restructuring charges, primarily severance costs, from the Company's international and U.S. headquarters operations. Cash, cash equivalents and marketable securities were $37.3 million as of March 31, 2008. Net cash usage was $11.2 million for the first quarter of 2008.
|
|
|
|
|
|
|
|
|
|
|